PERSERIS 90 mg in 0.6 mL Prefilled Syringe
RxNorm 2055676
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2055676 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: PERSERIS 90 mg in 0.6 mL Prefilled Syringe.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
0.6 mL Perseris 150 mg/ML Prefilled Syringe
(Atom ID: 10331785)
SBDPrescribable
Semantic Branded Drug (SBD):
0.6 mL risperidone 150 mg/ML Prefilled Syringe [Perseris]
(Atom ID: 12364158)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
0.6 mL risperiDONE 150 mg/ML Prefilled Syringe [Perseris]
(Atom ID: 10332073)
PSNPrescribable
Prescribable Name (PSN):
PERSERIS 90 mg in 0.6 mL Prefilled Syringe
(Atom ID: 10331784)
SYPrescribable
Synonym (SY):
Perseris 90 mg per 0.6 mL Prefilled Syringe
(Atom ID: 10331786)
Patient Education
Risperidone Injection
Risperidone extended-release (long-acting) injection is used to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Risperidone extended-release injection is used alone or in combination with lithium (Lithobid) or valproate (Depacon) to treat people who have bipolar I disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of severe mania, and other abnormal moods). Risperidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.